Institute for Molecular Medicine Finland - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Institute for Molecular Medicine Finland (FIMM) is a research institute that conducts research activities in the fields of human genomics and personalized medicine. The institute develops diagnostics, treatment and prevention of common health problems using Finnish clinical and epidemiological study materials. It offers services such as cell line authentication, capillary sequencing, SNP genotyping and CNV analysis, gene expression analysis, assay development and screening format adaptation, secondary assay testing and microarray printing, among others. FIMMs technology centre offers bioinformatics, digital microscopy and molecular pathology, extracellular vesicles, genotyping, high content imaging and analysis, high throughput biomedicine (htb), IT, metabolomics, sequencing and single cell analytics, among others. The institute provides doctoral training, FIMMPOD Postdoctoral program and other activities. FIMM is headquartered in Helsinki, Finland.

Institute for Molecular Medicine Finland - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
UPM Biochemicals Partners with Institute for Molecular Medicine Finland 10
Labcyte And Institute For Molecular Medicine Finland Partner To Advance Personalized Medicine In Cancer Treatments 11
Labcyte Extends Agreement with Institute for Molecular Medicine Finland 12
Institute for Molecular Medicine Finland - Key Competitors 13
Institute for Molecular Medicine Finland - Key Employees 14
Institute for Molecular Medicine Finland - Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Government and Public Interest 16
Nov 15, 2017: New Study Suggests a Role for Gene Regulation in Schizophrenia 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List Of Tables


Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Key Facts 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Molecular Medicine Finland, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
UPM Biochemicals Partners with Institute for Molecular Medicine Finland 10
Labcyte And Institute For Molecular Medicine Finland Partner To Advance Personalized Medicine In Cancer Treatments 11
Labcyte Extends Agreement with Institute for Molecular Medicine Finland 12
Institute for Molecular Medicine Finland, Key Competitors 13
Institute for Molecular Medicine Finland, Key Employees 14

List Of Figures


Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

The Sheikh Zayed Institute for Pediatric Surgical Innovation - Product Pipeline Analysis, 2019 Update

The Sheikh Zayed Institute for Pediatric Surgical Innovation (Sheikh Zayed Institute) is a non-for-profit organization that offers hosting pediatric device innovation symposium. The organizations services include infrastructure for R&D and

USD 750 View Report

Baker IDI Heart and Diabetes Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Baker IDI Heart and Diabetes Institute (Baker Institute) is a medical research organization that offers diagnosis, prevention, treatment of diabetics and cardiovascular disease. The organization offers clinical services such as

USD 250 View Report

The Sheikh Zayed Institute for Pediatric Surgical Innovation - Product Pipeline Analysis, 2019 Update

The Sheikh Zayed Institute for Pediatric Surgical Innovation (Sheikh Zayed Institute) is a non-for-profit organization that offers hosting pediatric device innovation symposium. The organizations services include infrastructure for R&D and

USD 750 View Report

Institute for Molecular Medicine Finland - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Institute for Molecular Medicine Finland (FIMM) is a research institute that conducts research activities in the fields of human genomics and personalized medicine. The institute develops diagnostics, treatment and prevention

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available